T
Treace Medical Concepts, Inc.
TMCI · NASDAQ · Healthcare · 311M
Closing price
$3.95
+1.94% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.9×
Enterprise value / EBITDAEV/EBITDA
-5.9×
Free cash flow yieldFCF yield
-11.8%
Return on equityROE
-67.6%
Operating margin
-25.5%
Net debt / EBITDAbalance-sheet strength
-0.1×
Interest coverage
-10.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.